Considering that we observed an increased number of edited sites on 3′UTRs, in the breast cells lines editing analysis, and the growing number of works that have described an ADAR1 role at UTRs regions [21, 22], we explored the possible implications of RNA editing activity at UTR regions in BC patients. The gene discussed is ADAR; the disease is breast cancer.